Evidence map›Paper›PMID 38249811›Full record

ArticleOncology letters2024

Prognostic effect of programmed cell death ligand 1/programmed cell death 1 expression in cancer stem cells of human oral squamous cell carcinoma.

Keita Todoroki, Yushi Abe, Katsuhisa Matsuo, Hidetoshi Nomura, Akihiko Kawahara, Yoshiaki Nakamura, Moriyoshi Nakamura, Naoko Seki, Jingo Kusukawa

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Keita TodorokiDental and Oral Medical Center, Kurume University, School of Medicine, Kurume, Fukuoka 830-0011, Japan.
Yushi AbeDental and Oral Medical Center, Kurume University, School of Medicine, Kurume, Fukuoka 830-0011, Japan.
Katsuhisa MatsuoDental and Oral Medical Center, Kurume University, School of Medicine, Kurume, Fukuoka 830-0011, Japan.
Hidetoshi NomuraDental and Oral Medical Center, Kurume University, School of Medicine, Kurume, Fukuoka 830-0011, Japan.
Akihiko KawaharaDepartment of Diagnostic Pathology, Kurume University Hospital, Kurume, Fukuoka 830-0011, Japan.
Yoshiaki NakamuraDepartment of Dentistry and Oral Surgery, Oita Saiseikai Hita Hospital, Hita, Oita 877-1292, Japan.
Moriyoshi NakamuraDental and Oral Medical Center, Kurume University, School of Medicine, Kurume, Fukuoka 830-0011, Japan.
Naoko SekiDental and Oral Medical Center, Kurume University, School of Medicine, Kurume, Fukuoka 830-0011, Japan.
Jingo KusukawaDental and Oral Medical Center, Kurume University, School of Medicine, Kurume, Fukuoka 830-0011, Japan.
Kurume University Medical Center · JPKurume University Hospital · JPSaiseikai Suita Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The relationship between cancer stem cells (CSCs) in oral squamous cell carcinoma (OSCC) and programmed cell death ligand 1 (PD-L1)/programmed cell death 1 (PD-1) remains unclear. Therefore, the present study aimed to clarify the association between the CD44v3

Indexed as

CD24CD44v3CSCimmune checkpoint inhibitorsOSCCprogrammed cell death 1programmed cell death ligand 1

Identifiers

PMID38249811
PMCPMC10797318
OpenAlexW4390588265

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.